FDA issues safety alert on fecal transplants after patient dies

Two adults with weakened immune systems who received investigational fecal microbiota transplantations developed invasive infections caused by extended-spectrum beta-lactamase -producing Escherichia coli, according to an FDA press release.
One of those individuals subsequently died.
As a result, the FDA issued a safety alert on Thursday to inform health care providers and patients of the possible risks for contracting serious infections when using FMT.
The FMT conducted in the two patients was prepared from stool obtained from the same donor, according to the release. However, according to the

Source link

Related posts

MRI finds more cases of liver cancer than ultrasonography in less time


The Complex Role of Trypsin in Pancreatitis


Lynch Syndrome Awareness Day Brings Attention to Hereditary Colorectal Cancer Syndromes


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World